Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Cisplatin/Capecitabine
Sponsor: Chinese Academy of Medical Sciences